3.22.0.1 html 222 430 1 false 75 0 false 7 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.arenapharm.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0002002 - Document - Audit Information Sheet http://www.arenapharm.com/role/AuditInformation Audit Information Notes 2 false false R3.htm 1001003 - Statement - Consolidated Balance Sheets Sheet http://www.arenapharm.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Uncategorized 3 false false R4.htm 1002004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.arenapharm.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Cover 4 false false R5.htm 1003005 - Statement - Consolidated Statements of Operations and Comprehensive (Loss) Income Sheet http://www.arenapharm.com/role/ConsolidatedStatementsofOperationsandComprehensiveLossIncome Consolidated Statements of Operations and Comprehensive (Loss) Income Statements 5 false false R6.htm 1004006 - Statement - Consolidated Statements of Equity Sheet http://www.arenapharm.com/role/ConsolidatedStatementsofEquity Consolidated Statements of Equity Statements 6 false false R7.htm 1005007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.arenapharm.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101101 - Disclosure - The Company and Summary of Significant Accounting Policies Sheet http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPolicies The Company and Summary of Significant Accounting Policies Notes 8 false false R9.htm 2106102 - Disclosure - Fair Value Disclosures Sheet http://www.arenapharm.com/role/FairValueDisclosures Fair Value Disclosures Notes 9 false false R10.htm 2109103 - Disclosure - Investments, Available-for-Sale Sheet http://www.arenapharm.com/role/InvestmentsAvailableforSale Investments, Available-for-Sale Notes 10 false false R11.htm 2112104 - Disclosure - Balance Sheet Details Sheet http://www.arenapharm.com/role/BalanceSheetDetails Balance Sheet Details Notes 11 false false R12.htm 2116105 - Disclosure - Leases Sheet http://www.arenapharm.com/role/Leases Leases Notes 12 false false R13.htm 2121106 - Disclosure - Equity Method Investment Sheet http://www.arenapharm.com/role/EquityMethodInvestment Equity Method Investment Notes 13 false false R14.htm 2126107 - Disclosure - Stockholders' Equity Sheet http://www.arenapharm.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 2134108 - Disclosure - Collaborations and License Agreements Sheet http://www.arenapharm.com/role/CollaborationsandLicenseAgreements Collaborations and License Agreements Notes 15 false false R16.htm 2138109 - Disclosure - Income Taxes Sheet http://www.arenapharm.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 2145110 - Disclosure - Legal Proceedings Sheet http://www.arenapharm.com/role/LegalProceedings Legal Proceedings Notes 17 false false R18.htm 2146111 - Disclosure - Subsequent Event Sheet http://www.arenapharm.com/role/SubsequentEvent Subsequent Event Notes 18 false false R19.htm 2202201 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies) Sheet http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies The Company and Summary of Significant Accounting Policies (Policies) Policies http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPolicies 19 false false R20.htm 2303301 - Disclosure - The Company and Summary of Significant Accounting Policies (Tables) Sheet http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesTables The Company and Summary of Significant Accounting Policies (Tables) Tables http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPolicies 20 false false R21.htm 2307302 - Disclosure - Fair Value Disclosures (Tables) Sheet http://www.arenapharm.com/role/FairValueDisclosuresTables Fair Value Disclosures (Tables) Tables http://www.arenapharm.com/role/FairValueDisclosures 21 false false R22.htm 2310303 - Disclosure - Investments, Available-for-Sale (Tables) Sheet http://www.arenapharm.com/role/InvestmentsAvailableforSaleTables Investments, Available-for-Sale (Tables) Tables http://www.arenapharm.com/role/InvestmentsAvailableforSale 22 false false R23.htm 2313304 - Disclosure - Balance Sheet Details (Tables) Sheet http://www.arenapharm.com/role/BalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://www.arenapharm.com/role/BalanceSheetDetails 23 false false R24.htm 2317305 - Disclosure - Leases (Tables) Sheet http://www.arenapharm.com/role/LeasesTables Leases (Tables) Tables http://www.arenapharm.com/role/Leases 24 false false R25.htm 2322306 - Disclosure - Equity Method Investment (Tables) Sheet http://www.arenapharm.com/role/EquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://www.arenapharm.com/role/EquityMethodInvestment 25 false false R26.htm 2327307 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.arenapharm.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.arenapharm.com/role/StockholdersEquity 26 false false R27.htm 2335308 - Disclosure - Collaborations and License Agreements (Tables) Sheet http://www.arenapharm.com/role/CollaborationsandLicenseAgreementsTables Collaborations and License Agreements (Tables) Tables http://www.arenapharm.com/role/CollaborationsandLicenseAgreements 27 false false R28.htm 2339309 - Disclosure - Income Taxes (Tables) Sheet http://www.arenapharm.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.arenapharm.com/role/IncomeTaxes 28 false false R29.htm 2404401 - Disclosure - The Company and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail The Company and Summary of Significant Accounting Policies - Additional Information (Detail) Details 29 false false R30.htm 2405402 - Disclosure - The Company and Summary of Significant Accounting Policies - Reconciliation of Components of Cash, Cash Equivalents and Restricted Cash (Detail) Sheet http://www.arenapharm.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesReconciliationofComponentsofCashCashEquivalentsandRestrictedCashDetail The Company and Summary of Significant Accounting Policies - Reconciliation of Components of Cash, Cash Equivalents and Restricted Cash (Detail) Details 30 false false R31.htm 2408403 - Disclosure - Fair Value Disclosures - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.arenapharm.com/role/FairValueDisclosuresFinancialAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail Fair Value Disclosures - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 31 false false R32.htm 2411404 - Disclosure - Investments, Available-for-Sale (Detail) Sheet http://www.arenapharm.com/role/InvestmentsAvailableforSaleDetail Investments, Available-for-Sale (Detail) Details http://www.arenapharm.com/role/InvestmentsAvailableforSaleTables 32 false false R33.htm 2414405 - Disclosure - Balance Sheet Details - Land, Property and Equipment, Net (Detail) Sheet http://www.arenapharm.com/role/BalanceSheetDetailsLandPropertyandEquipmentNetDetail Balance Sheet Details - Land, Property and Equipment, Net (Detail) Details 33 false false R34.htm 2415406 - Disclosure - Balance Sheet Details - Accounts Payable and Other Accrued Liabilities (Detail) Sheet http://www.arenapharm.com/role/BalanceSheetDetailsAccountsPayableandOtherAccruedLiabilitiesDetail Balance Sheet Details - Accounts Payable and Other Accrued Liabilities (Detail) Details 34 false false R35.htm 2418407 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.arenapharm.com/role/LeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 35 false false R36.htm 2419408 - Disclosure - Leases - Future Minimum Lease Payments (Detail) Sheet http://www.arenapharm.com/role/LeasesFutureMinimumLeasePaymentsDetail Leases - Future Minimum Lease Payments (Detail) Details 36 false false R37.htm 2420409 - Disclosure - Leases - Expected Minimum Rental Payments to be Received under Sublease (Detail) Sheet http://www.arenapharm.com/role/LeasesExpectedMinimumRentalPaymentstobeReceivedunderSubleaseDetail Leases - Expected Minimum Rental Payments to be Received under Sublease (Detail) Details 37 false false R38.htm 2423410 - Disclosure - Equity Method Investment - Narrative (Details) Sheet http://www.arenapharm.com/role/EquityMethodInvestmentNarrativeDetails Equity Method Investment - Narrative (Details) Details 38 false false R39.htm 2424411 - Disclosure - Equity Method Investment - Carrying Value (Details) Sheet http://www.arenapharm.com/role/EquityMethodInvestmentCarryingValueDetails Equity Method Investment - Carrying Value (Details) Details 39 false false R40.htm 2425412 - Disclosure - Equity Method Investment - Activity (Details) Sheet http://www.arenapharm.com/role/EquityMethodInvestmentActivityDetails Equity Method Investment - Activity (Details) Details 40 false false R41.htm 2428413 - Disclosure - Stockholders' Equity - Narrative (Detail) Sheet http://www.arenapharm.com/role/StockholdersEquityNarrativeDetail Stockholders' Equity - Narrative (Detail) Details 41 false false R42.htm 2429414 - Disclosure - Stockholders Equity - Schedule of Share Based Compensation (Details) Sheet http://www.arenapharm.com/role/StockholdersEquityScheduleofShareBasedCompensationDetails Stockholders Equity - Schedule of Share Based Compensation (Details) Details 42 false false R43.htm 2430415 - Disclosure - Stockholders' Equity - Schedule of Share Based Compensation Expense by Grant Type (Details) Sheet http://www.arenapharm.com/role/StockholdersEquityScheduleofShareBasedCompensationExpensebyGrantTypeDetails Stockholders' Equity - Schedule of Share Based Compensation Expense by Grant Type (Details) Details 43 false false R44.htm 2431416 - Disclosure - Stockholders' Equity - Weighted-Average Assumptions and Estimated Fair Value of Stock Options (Detail) Sheet http://www.arenapharm.com/role/StockholdersEquityWeightedAverageAssumptionsandEstimatedFairValueofStockOptionsDetail Stockholders' Equity - Weighted-Average Assumptions and Estimated Fair Value of Stock Options (Detail) Details 44 false false R45.htm 2432417 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Detail) Sheet http://www.arenapharm.com/role/StockholdersEquitySummaryofStockOptionActivityDetail Stockholders' Equity - Summary of Stock Option Activity (Detail) Details 45 false false R46.htm 2433418 - Disclosure - Stockholders' Equity - Schedule of Restricted Stock and Performance Stock (Detail) Sheet http://www.arenapharm.com/role/StockholdersEquityScheduleofRestrictedStockandPerformanceStockDetail Stockholders' Equity - Schedule of Restricted Stock and Performance Stock (Detail) Details 46 false false R47.htm 2436419 - Disclosure - Collaborations and License Agreements - Summary of Revenue Disaggregated by Major Customers, Timing of Revenue Recognition and Revenue Classification (Detail) Sheet http://www.arenapharm.com/role/CollaborationsandLicenseAgreementsSummaryofRevenueDisaggregatedbyMajorCustomersTimingofRevenueRecognitionandRevenueClassificationDetail Collaborations and License Agreements - Summary of Revenue Disaggregated by Major Customers, Timing of Revenue Recognition and Revenue Classification (Detail) Details 47 false false R48.htm 2437420 - Disclosure - Collaborations and License Agreements - Additional Information (Detail) Sheet http://www.arenapharm.com/role/CollaborationsandLicenseAgreementsAdditionalInformationDetail Collaborations and License Agreements - Additional Information (Detail) Details 48 false false R49.htm 2440421 - Disclosure - Income Taxes - Summary of (Loss) Income Before Provision (Benefit) for Income Taxes by Region (Detail) Sheet http://www.arenapharm.com/role/IncomeTaxesSummaryofLossIncomeBeforeProvisionBenefitforIncomeTaxesbyRegionDetail Income Taxes - Summary of (Loss) Income Before Provision (Benefit) for Income Taxes by Region (Detail) Details 49 false false R50.htm 2441422 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.arenapharm.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 50 false false R51.htm 2442423 - Disclosure - Income Taxes - Reconciliation of Provision (Benefit) for Income Taxes at Statutory Federal Rate to Provision (Benefit) for Income Taxes (Detail) Sheet http://www.arenapharm.com/role/IncomeTaxesReconciliationofProvisionBenefitforIncomeTaxesatStatutoryFederalRatetoProvisionBenefitforIncomeTaxesDetail Income Taxes - Reconciliation of Provision (Benefit) for Income Taxes at Statutory Federal Rate to Provision (Benefit) for Income Taxes (Detail) Details 51 false false R52.htm 2443424 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets (Detail) Sheet http://www.arenapharm.com/role/IncomeTaxesComponentsofNetDeferredTaxAssetsDetail Income Taxes - Components of Net Deferred Tax Assets (Detail) Details 52 false false R53.htm 2444425 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail) Sheet http://www.arenapharm.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetail Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail) Details 53 false false R54.htm 2447426 - Disclosure - Subsequent Event (Detail) Sheet http://www.arenapharm.com/role/SubsequentEventDetail Subsequent Event (Detail) Details http://www.arenapharm.com/role/SubsequentEvent 54 false false All Reports Book All Reports arna-20211231.htm arna-20211231.xsd arna-20211231_cal.xml arna-20211231_def.xml arna-20211231_lab.xml arna-20211231_pre.xml arna-20211231xexx1029.htm arna-20211231xexx1030.htm arna-20211231xexx105.htm arna-20211231xexx1053.htm arna-20211231xexx1059.htm arna-20211231xexx211.htm arna-20211231xexx231.htm arna-20211231xexx311.htm arna-20211231xexx312.htm arna-20211231xexx321.htm arna-20211231_g1.gif arna-20211231_g2.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true